medigraphic.com
Instituto Nacional de Neurología y Neurocirugía

2021, Number 1

<< Back Next >>

Arch Neurocien 2021; 26 (1)

Prevalence of depression in adults with type 2 diabetes mellitus and associated factors

Guarneros-Soto N, Merino-Zeferino B, Ruíz-Jiménez LC, Juárez-Martínez L, Tapia-Plascencia MP, García-Villegas EA

Language: Spanish
References: 34
Page: 8-14
PDF size: 270.20 Kb.


ABSTRACT

Introduction: People with type 2 diabetes can suffer psychological disorders such as depression, which affect their physical, mental, and emotional state. Objective: The aim of this study to identify the prevalence of depression and factors associated with depressive symptoms in adults with type 2 diabetes.
Material and methods: Cross-sectional study in 155 adults with type 2 diabetes from Mexico City. Sociodemographic, anthropometric, clinical, diet and habits characteristics were evaluated. Depressive symptoms were measured with the Zung Self-Rating Depression Scale. Logistic regression analysis was performed.
Results: The prevalence of depressive symptoms was 29.7%. The associated factors were physical inactivity, living alone, a lower educational level, hypertension, hyperglycemia, and the duration of diabetes. The risk of having depressive symptoms was 2.1 (95% CI 1.0 - 4.7) with glucose values ≥130 mg / dL, 3.6 (95% CI 1.2-11) for hypertension, 3.5 (95% CI 1.3-9.5) when living alone and 2.9 (CI95% 1.3-6.4) due to physical inactivity.
Discussion: The factors associated with depression in patients with T2D were hyperglycemia, hypertension, longer duration of diabetes, a lower educational level and living alone. Blood glucose concentrations and longer duration of diabetes in years were the variables that explained a higher score for depressive symptoms.
Conclusions: Lack of recognition of depressive symptoms or late detection leads to complications of diabetes. These patients require adequate health education, with support to develop self-care and emotional adjustment strategies against depression.


REFERENCES

  1. Parameshwari K. Depression, anxiety, and stress levels in patients with type 2 diabetes mellitus. Natl J Physiol Pharm Pharmacol. 2018;8(11):1570. doi: 10.5455/njppp.2018.8.0929117092018

  2. Semenkovich K, Brown ME, Svrakic DM, Lustman PJ. Depression in type 2 diabetes mellitus: prevalence, impact, and treatment. Drugs 2015; 75(6):577-87. DOI: 10.1007/s40265-015-0347-4

  3. De la Roca-Chiapas JM, Hernández-González M, Candelario M, Villafaña M, Hernández E, Solorio S, et al. Association between depression and higher glucose levels in middle-aged Mexican patients with diabetes. Rev Invest Clin 2013; 65 (3):209-13.

  4. Rivarola Sosa A, Brizuela M, Rolón-Ruiz Díaz A. Depression level according to the chronicity of type 2 Diabetes Mellitus and its comorbidities in patients of the Health Units, Encarnación, Paraguay 2018. Rev Salud publica Parag 2019; 9(2):9-15. https://doi.org/10.18004/rspp.2019.diciembre.9-15

  5. Salinero-Fort MA, Gómez-Campelo P, San Andrés-Rebollo FJ, Cárdenas- Valladolid J, Abánades-Herranz JC, Carrillo de Santa Pau E, et al. Prevalence of depression in patients with type 2 diabetes mellitus in Spain (the DIADEMA Study): results from the MADIABETES cohort. BMJ Open 2018; 8(9):e020768. DOI: 10.1136/bmjopen-2017-020768

  6. Asuzu CC, Walker RJ, Williams JS, Egede LE. Pathways for the relationship between diabetes distress, depression, fatalism and glycemic control in adults with type 2 diabetes. J Diabetes Complications 2017; 31(1):169– 74. doi: 10.1016/j.jdiacomp.2016.09.013.

  7. Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. J Affect Disord 2012;142:S8–21. DOI: 10.1016/S0165- 0327(12)70004-6

  8. Encuesta Nacional de Salud y Nutrición 2018 Presentación de resultados [Internet]. CDMX: INSP; 2019 [citado 23 abril 2020]. Disponible en: https://ensanut.insp.mx/encuestas/ensanut2018/doctos/informes/ ensanut_2018_presentacion_resultados.pdf

  9. Medina–Mora ME, Borges G, Lara C, Benjet C, Blanco J et al. Prevalence, service use, and demographic correlates of 12–month DSM–IV psychiatric disorders in Mexico: results from the Mexican National Comorbidity Survey. Psychol Med 2005; 35(12):1773-1783. DOI: 10.1017/ S0033291705005672

  10. Gonzalez J, Peyrot M, McCarl L, Collins E, Serpa L, Mimiaga M, et al. Depression and Diabetes Treatment Nonadherence: A Meta-Analysis. Diabetes Care 2008;31(12):2398-403. https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC2584202/

  11. Lustman PJ, Clouse RE. Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications 2005;19(2):113-22. DOI: 10.1016/j.jdiacomp.2004.01.002

  12. Richardson LK, Egede LE, Mueller M, Echols CL, Gebregziabher M. Longitudinal effects of depression on glycemic control in veterans with Type 2 diabetes. Gen Hosp Psychiatry 2008;30(6):509-14. doi: 10.1016/j. genhosppsych.2008.07.001

  13. Holt R, de Groot M, Golden S. Diabetes and Depression. Curr Diab Rep 2014;14(6):491. DOI: 10.1007/s11892-014-0491-3

  14. Wu SF, Huang YC, Liang SY, Wang TJ, Lee MC, Tung HH. Relationships among depression, anxiety, self-care behaviour and diabetes education difficulties in patients with type-2 diabetes: a cross-sectional questionnaire survey. Int J Nurs Stud 2011;48(11):1376–83. DOI: 10.1016/j. ijnurstu.2011.04.008

  15. Weikert B, Buttery AK, Heidemann C, Rieckmann N, Paprott R, Maske U.E, et al. Glycaemic status and depressive symptoms among adults in Germany: results from the German Health Interview and Examination Survey for Adults (DEGS1).Diabet Med. 2018;35(11):1552-61. DOI: 10.1111/dme.13707

  16. Zhang W, Xu H, Zhao S, Yin S, Wang X, Guo J, et al. Prevalence and influencing factors of co-morbid depression in patients with type 2 diabetes mellitus: a General Hospital based study. Diabetol Metab Syndr 2015;7(1):60. DOI: 10.1186/s13098-015-0053-0

  17. Antunez M, Bettiol AA. Depresión en pacientes con diabetes tipo 2 que acuden a una consulta externa de Medicina Interna. Acta Med Colomb 2017;41(2):102-10.http://www.actamedicacolombiana.com/anexo/ articulos/2016/02-2016-05.pdf

  18. van Steenbergen-Weijenburg KM, van Puffelen AL, Horn EK, Nuyen J, van Dam PS, van Benthem TB, et al. More co-morbid depression in patients with Type 2 diabetes with multiple complications. An observational study at a specialized outpatient clinic. Diabet Med 2011;28(1):86-9. DOI: 10.1111/j.1464-5491.2010.03125.x

  19. Brown S, García A, Brown A, Becker B, Conn V, Ramírez G, et al. Biobehavioral determinants of glycemic control in type 2 diabetes: A systematic review and meta-analysis. Patient Educ Couns. 2016; 99(10):1558–67. DOI: 10.1016/j.pec.2016.03.020

  20. Lohman T, Roche A, Martorell R, editores. Part I. Measurement Descriptions and Techniques; Circumferences. In; Anthropometric Standardization Reference Manual. Human Kinetics Books; 1991.

  21. Habitch J. Estandarización de métodos epidemiológicos cuantitativos sobre el terreno. Boletín de la Oficina Sanitaria Panamericana. 1974; 76:375-85. https://iris.paho.org/handle/10665.2/10766

  22. Moreno-González. M. I. Circunferencia de cintura: una medición importante y útil del riesgo cardiometabólico. Rev Chil Cardiol. 2010; 29(1):85-87. http://dx.doi.org/10.4067/S0718-85602010000100008

  23. NORMA Oficial Mexicana NOM-043-SSA2-2012, Servicios básico de salud. Promoción y educación para la salud en materia alimentaria. Criterios para brindar orientación. Diario Oficial de la Federación. Secretaria de Salud. Martes 22 de enero de 2013. https://www.cndh.org. mx/DocTR/2016/JUR/A70/01/JUR-20170331-NOR37.pdf

  24. American Diabetes Association. Diabetes Care Jan 2020, 43 (Supplement 1) S66-S76; DOI: 10.2337/dc20-S006

  25. Gijón-Conde T, Gorostidi M, Camafort M, Abad-Cardiel M, Martín- Rioboo E, Morales-Olivas F, et al. Documento de la Sociedad Española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA) sobre las guías ACC/AHA 2017 de hipertensión arterial. Hipertens Riesgo Vasc 2018; 35 (3):119-29. https://www.seh-lelha.org/ wp-content/uploads/2018/06/TGijonDoc_SEHLELHAGuiasAHA2017. pdf

  26. Sistemas de recetas y cálculo nutrimental. Departamento Nutrición Aplicada y Educación Nutricional, INCMNSZ 2018, Ciudad de México.

  27. Miller LH, Smith AD. Stress Audit Questionnaire Your Life and Health. Centro Medico Universidad de Boston. 1983; 98, 20-30.

  28. Zung W. A self-rating depression scale. Arch Gen Psychiatr 1965; 12(1):63-70. doi: 10.1001/archpsyc.1965.01720310065008.

  29. Conde V, Escribá JA, Izquierdo J. Evaluación estadística y adaptación castellana de la escala auto aplicada para la depresión de Zung. Arch Neurobiol, 1970; 33:185-206.

  30. IBM Corp. Released 2012. IBM SPSS Statistics for Windows, Version 21.0. Armonk, NY: IBM Corp.

  31. Rivas-Acuña V, García-Barjau H, Cruz-León A, Morales-Ramón F, Enríquez-Martínez RM, Román-Alvarez J. Prevalencia de ansiedad y depresión en las personas con diabetes mellitus tipo 2. Salud en Tabasco 2011; 17(1):30-5. https://www.redalyc.org/pdf/487/48721182005.pdf

  32. Valladares-Garrido MJ, Soriano-Moreno AN, Rodrigo-Gallardo PK, Moncada-Mapelli E, Pacheco-Mendoza J, Toro-Huamanchumo CJ. Depression among Peruvian adults with hypertension and diabetes: Analysis of a national survey. Diabetes Metab Syndr 2020;14(2):141-46. 10.1016/j.dsx.2020.02.001

  33. Zhang Y, Chen Y, Ma L. Depression and cardiovascular disease in elderly: Current understanding. J Clin Neurosci 2018; 47:1-5. DOI: 10.1016/j. jocn.2017.09.022

  34. Weber B, Schweiger U, Deuschle M, Heuser I. Major depression and impaired glucose tolerance. Exp Clin Endocrinol Diabetes.2000;108(3):187-90. DOI: 10.1055/s-2000-7742




2020     |     www.medigraphic.com